Does a decrease in the T-score interval on a bone density report compared to the previous year indicate an improvement in bone mineral density?

No, a "decrease in the interval" of the T-score indicates worsening bone mineral density, not improvement.

A decrease in T-score means bone density has declined and represents deterioration of bone health. This is a critical point of confusion that can lead to misinterpretation of bone density reports and inappropriate clinical decisions.

Understanding T-Score Direction

The T-score scale works in a counterintuitive way for many clinicians:

• Higher (less negative) T-scores = Better bone density

  • Example: Moving from -2.5 to -2.0 is improvement

• Lower (more negative) T-scores = Worse bone density

  • Example: Moving from -2.0 to -2.5 is worsening

According to WHO criteria, T-scores are interpreted as follows 1:

• T-score ≥ -1.0 = Normal BMD
• T-score between -1.0 and -2.5 = Osteopenia/low bone mass
• T-score ≤ -2.5 = Osteoporosis

What "Decrease in the Interval" Means

When a report states there is a "decrease in the interval" from last year to now, this means:

• The T-score number has become more negative
• The patient has lost bone density
• The fracture risk has increased

Example Scenario:

• Last year: T-score = -2.0 (osteopenia)
• This year: T-score = -2.3 (still osteopenia, but worse)
• This represents a decrease in T-score and indicates bone loss

Clinical Implications

This finding should prompt immediate action:

1. Reassess current osteoporosis therapy - If the patient is on treatment, the current regimen is not adequately preventing bone loss

2. Evaluate medication adherence - Poor compliance is a common cause of continued bone loss despite treatment

3. Screen for secondary causes - Consider vitamin D deficiency, hyperparathyroidism, malabsorption, medications (glucocorticoids), or other metabolic bone diseases

4. Consider treatment intensification - Research shows that IV bisphosphonates and denosumab achieve better BMD increases (0.54% and 1.23% respectively) compared to oral bisphosphonates 2

Common Pitfall to Avoid

The most critical error is misinterpreting "decrease" as improvement simply because the word "decrease" might sound positive in casual language. In the context of T-scores, decrease always means worsening. When reviewing serial BMD studies, repeat measurements should be conducted at the same facility with the same DXA system to ensure accurate comparison 1.

Studies demonstrate that most patients (69%) remain in the same T-score category over time, and improvement to a better category occurs in only 15-41% of patients depending on baseline severity 2. Therefore, any documented decrease in T-score represents a clinically significant finding requiring intervention.